Skip to content

Evaluation of the therapeutic effect of botulinum toxin injection on frowning muscle using new ultrasound technology

Application study of high-frequency ultrasound combined with multimodal ultrasound in evaluating the "structure function" of frown muscle before and after injection of toxin

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600119617
Enrollment
Unknown
Registered
2026-03-01
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Botulinum toxin injection for treating frown lines

Interventions

Case group:None
Control group:None

Sponsors

PEKING UNIVERSITY SHENZHEN HOSPITAL
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.The case group consisted of patients who received botulinum toxin injections into the corrugator supercilii muscle. The inclusion criteria were as follows: 1)age >=18 years, any gender;2)Botulinum toxin has already been injected into the corrugator muscles, and the injection plan (drug brand, dosage, injection points) is clearly documented;3)HFUS multimodal ultrasound examination was completed after the injection. 2.The control group consisted of patients who underwent corrugator supercilii muscle examination in our hospital during the same period and had no history of facial plastic surgery or botulinum toxin injection. The inclusion criteria were as follows: 1) age >=18 years, any gender; 2) no facial muscle diseases (such as myasthenia) or skin diseases (such as severe acne, scars); 3) completed corrugator supercilii HFUS + multimodal ultrasound examination.

Exclusion criteria

Exclusion criteria: 1.Exclusion criteria for the case group:1)The retained ultrasound images are unclear (such as blurred boundaries of the corrugator muscle and invalid elastography data);2)Lack of complete clinical data (such as missing injection doses and ultrasound examination time point data);3)There is active infection at the injection site, severe acne or skin lesions. 2.Exclusion criteria for the control group:1)The retained ultrasound images are unclear (such as blurred boundaries of the corrugator muscle and invalid elastography data);2)Lack of complete clinical data (such as missing injection doses and ultrasound examination time point data);3)Receiving other facial anti-aging treatments at the same time (such as hyaluronic acid fillers or radiofrequency skin tightening) may affect the assessment of the corrugator muscle.

Design outcomes

Primary

MeasureTime frame
Muscle thickness;Muscle stiffness;Muscle echo;

Countries

China

Contacts

Public ContactYang Qi

PEKING UNIVERSITY SHENZHEN HOSPITAL

yangqi198903@126.com+86 755 83923333

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 14, 2026